Cinnarizine Mechanism of Action
Cinnarizine is a piperazine derivative that works primarily through multiple mechanisms: blocking voltage-gated calcium channels, antagonizing histamine H1 receptors, blocking dopamine D2 receptors, and antagonizing serotonin receptors 1.
Primary Mechanisms
Calcium Channel Blockade
Cinnarizine's most clinically relevant action is blocking voltage-gated calcium channels, particularly in vestibular hair cells and vascular smooth muscle 2. This mechanism:
- Reduces calcium influx into cells
- Inhibits calcium-dependent potassium currents in vestibular hair cells
- Prevents pressure-induced currents in the inner ear that contribute to vertigo symptoms 2
- Produces vasodilatory effects by relaxing vascular smooth muscle
The calcium channel blocking activity occurs at therapeutic concentrations (IC50 of 0.19 μM for membrane potential effects) 2, making this a primary therapeutic mechanism rather than an off-target effect.
Histamine H1 Receptor Antagonism
Cinnarizine acts as an antihistaminic agent through H1 receptor blockade 1. This contributes to:
- Anti-nausea effects
- Reduction of vestibular symptoms
- Management of motion sickness
Dopamine D2 Receptor Antagonism
The drug exhibits moderate dopamine D2 receptor antagonism 3, 1. This mechanism:
- Contributes to antiemetic effects
- Explains the rare extrapyramidal side effects seen in elderly patients
- May interfere with catecholamine storage in vesicles by uncoupling the vacuolar H+-ATPase (IC50 5.9 μM) 4
Important caveat: The dopaminergic effects can cause drug-induced parkinsonism, particularly in elderly patients or with prolonged use, as cinnarizine inhibits dopamine uptake into storage vesicles at therapeutic plasma concentrations 4.
Antiserotonergic Activity
Cinnarizine also demonstrates serotonin receptor antagonism 1, which may contribute to its antivertigo and anti-nausea properties.
Clinical Implications
The multi-receptor profile explains cinnarizine's efficacy in vestibular vertigo:
- Peripheral action: Calcium channel blockade directly affects vestibular hair cells and reduces abnormal vestibular signals 2, 5
- Central action: H1 and dopamine receptor antagonism modulates central vestibular processing 5
- Vascular effects: Calcium channel blockade improves inner ear microcirculation
When combined with dimenhydrinate (which acts centrally on vestibular nuclei), the fixed combination provides both peripheral and central vestibular suppression, explaining superior efficacy versus monotherapy 6, 7.
Safety Consideration
The dopamine D2 antagonism at therapeutic doses (5.9 μM) means cinnarizine can interfere with normal dopaminergic function 4. Monitor elderly patients for extrapyramidal symptoms, though these occur infrequently at standard doses. The drug's ability to uncouple the vacuolar H+-ATPase and inhibit dopamine storage may contribute to parkinsonian side effects with chronic use 4.